Peer Reviewers

We gratefully acknowledge the contributions of all peer reviewers. Cochrane Gut aims to involve clinical peer and consumer reviewers in the assessment of all protocols and reviews before publication. The following people have contributed to the peer-review process. Contributors are listed from June 2020 onward (reflecting the timing of the Cochrane Gut merger). We also thank the peer reviewers who have chosen not to be publicly acknowledged.

2022
Marc G Besselink, Katharine Ker, Ove B Schaffalitzky de Muckadell, Marilyn Walsh, Ali Zarrinpar

2021
Derek Alderson, Azhar Ansari, Desiree Baaleman, Francesco E Botelho, Martin Brand, Gala Godoy Brewer, Mhairi Campbell, Omar Cauli, Naoki Chiba, Kimberlee Daley,  Nanne de Boer, Alysia De Nino, Lissy de Ridder, Marco Gasparetto, Claudio Antonio AR Gomes Jr, John Gubatan, Gunadi, Barney Hawthorne, Kendra J Kamp, Nick Kennedy, Romaric Loffroy, Philippe Marteau, Rohin Mittal, Emma Neary, Sarah J Nevitt, Jean Marc Regimbeau, David Sachar, Efstatios Saliakellis, Mohammed Kareen Shariff, David Sachar, Efstratios Saliakellis, Arthur Schmidt, Christian Selinger, Farhad Shokraneh, Rujan Shrestha, Georgios Sgourakis, Kartikeya Tripathi, Jeanette Van Roosmalen, Marilyn Walsh, Brock Williams, John Windsor

2020
Steven J Allen, Siwar Al-Bashir, David Armstrong, Steven J Bickston, Sarah Blake, Kate Blakeley, Kim Tam Bui, Robert Cirocchi, Matthew D Coates, Dario Conte,  Joseph Curry, Kimberlee Daley, Bobby VM Dasari, Joanna Colleen Dionne, Sarah El-Nakeep, Daniel Gaya, Ewan Griffiths, John Gubatan, Stephen Hanauer, Andrea Iannone, Janusz Jankowski, Taher Kagalwala, Reena Khanna, Rakesh Kochhar, Maciek Kolodziej, Geertjan van Tienhoven, Berkeley N Limketkai, Doug MacKay, John K Marshall, Katherine Mason, Emma Neary, Maria Ines Pinto-Sanchez, Rodrigo Ramos, Pablo Serrano, Shinichiro Shinzaki, Anand Narayan Singh, Khaled Turkmani, Marilyn Walsh, Johanna W Wilmink, Yuan Zhang

We are also grateful to all peer reviewers who contributed to the evaluation of reviews for the former Cochrane Upper Gastrointestinal and Pancreatic Diseases and Cochrane IBD groups (now defunct) prior to the Cochrane Gut merger in 2020.